Left insular stroke is associated with adverse cardiac outcome

被引:176
作者
Laowattana, S
Zeger, SL
Lima, JAC
Goodman, SN
Wittstein, IS
Oppenheimer, SM
机构
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[4] New Jersey Neurosci Inst, Edison, NJ USA
关键词
D O I
10.1212/01.wnl.0000202684.29640.60
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: After stroke, 10% of patients have adverse cardiac outcomes. Left insular damage may contribute to this by impairing sympathovagal balance (associated with cardiac structural damage and arrhythmias). Methods: The authors conducted a prospective study of 32 patients with left insular stroke (Group 1) and 84 patients with non-insular stroke/TIA (Group 2). Adverse cardiac outcomes (cardiac death, myocardial infarction, angina, and heart failure) were assessed over 1 year. Myocardial wall motion was investigated with transesophageal echocardiography. Results: Group 1's cardiac outcome relative risk (RR) compared with Group 2 was 1.75 (95% CI: 1.02, 3.00, p = 0.05). Left insular stroke remained an independent predictor of cardiac outcome in multivariate analyses. Sensitivity analysis excluding TIA and angina showed similar results. For Group 1 patients without symptomatic coronary artery disease (SCAD), cardiac outcome RR = 4.06 (95% CI: 1.83, 9.01, p = 0.002). For Group 1 with SCAD, RR = 0.36 (95% CI: 0.06, 2.13, p = 0.14). Cardiac wall motion impairment was also associated with left insular stroke independent of CAD or nonischemic heart disease. Right insular stroke was not associated with adverse cardiac outcomes or cardiac wall motion impairment. Conclusions: Left insular stroke is associated with an increased risk of adverse cardiac outcome and decreased cardiac wall motion compared to stroke in other locations and TIA. This was particularly marked in patients without symptomatic coronary artery disease (SCAD). In patients with SCAD, the cardioprotective effect of medications, especially beta-blockers alone or combined with ischemic preconditioning, may explain the lack of association in this subgroup.
引用
收藏
页码:477 / 483
页数:7
相关论文
共 52 条
[21]   LEFT-VENTRICULAR WALL-MOTION ABNORMALITIES IN PATIENTS WITH SUBARACHNOID HEMORRHAGE - NEUROGENIC STUNNED MYOCARDIUM [J].
KONO, T ;
MORITA, H ;
KUROIWA, T ;
ONAKA, K ;
TAKATSUKA, H ;
FUJIWARA, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 24 (03) :636-640
[22]   SUPRAVENTRICULAR TACHYCARDIA IN PATIENTS WITH RIGHT-HEMISPHERE STROKES [J].
LANE, RD ;
WALLACE, JD ;
PETROSKY, PP ;
SCHWARTZ, GE ;
GRADMAN, AH .
STROKE, 1992, 23 (03) :362-366
[23]  
Lavados Pablo M., 1997, Stroke, V28, P238
[24]  
LEE JC, 1985, AM J PATHOL, V121, P316
[25]   MYOCARDIAL PROTECTION WITH PRECONDITIONING [J].
LI, GC ;
VASQUEZ, JA ;
GALLAGHER, KP ;
LUCCHESI, BR .
CIRCULATION, 1990, 82 (02) :609-619
[26]   Pulmonary and cardiac sequelae of subarachnoid haemorrhage: time for active management? [J].
Macmillan, CSA ;
Grant, IS ;
Andrews, PJD .
INTENSIVE CARE MEDICINE, 2002, 28 (08) :1012-1023
[27]   ADRENERGIC EFFECTS ON THE BIOLOGY OF THE ADULT MAMMALIAN CARDIOCYTE [J].
MANN, DL ;
KENT, RL ;
PARSONS, B ;
COOPER, G .
CIRCULATION, 1992, 85 (02) :790-804
[28]  
*MAPHY STUD GROUP, 1991, AM J HYPERTENS, V4, P151
[29]   Sympathetic nervous activity and myocardial damage immediately after subarachnoid hemorrhage in a unique animal model [J].
Masuda, T ;
Sato, K ;
Yamamoto, S ;
Matsuyama, N ;
Shimohama, T ;
Matsunaga, A ;
Obuchi, S ;
Shiba, Y ;
Shimizu, S ;
Izumi, T .
STROKE, 2002, 33 (06) :1671-1676
[30]   ELECTROCARDIOGRAPHIC MARKERS OF ABNORMAL LEFT-VENTRICULAR WALL-MOTION IN ACUTE SUBARACHNOID HEMORRHAGE [J].
MAYER, SA ;
LIMANDRI, G ;
SHERMAN, D ;
LENNIHAN, L ;
FINK, ME ;
SOLOMON, RA ;
DITULLIO, M ;
KLEBANOFF, LM ;
BECKFORD, AR ;
HOMMA, S .
JOURNAL OF NEUROSURGERY, 1995, 83 (05) :889-896